Condition Lookup
Sub-Category:
Immune-Mediated Toxicity
Number of Conditions: 1
Immunotherapy-related adverse effects
Specialty: Toxicology
Category: Adverse Effects of Therapeutics and Medical Agents
Sub-category: Immune-Mediated Toxicity
Symptoms:
fatigue; rash; diarrhea; colitis; pneumonitis; hepatitis; endocrinopathies (e.g., hypothyroidism, adrenal insufficiency)
Root Cause:
Overactivation of the immune system causes inflammation and damage to healthy tissues and organs.
How it's Diagnosed: videos
Clinical evaluation, blood tests (liver enzymes, thyroid function), imaging (e.g., chest CT for pneumonitis), and biopsies for organ-specific involvement.
Treatment:
Immunosuppressive therapy (e.g., corticosteroids), discontinuation of immunotherapy, and organ-specific management.
Medications:
Prednisone or methylprednisolone (corticosteroids), infliximab (anti-TNF for refractory colitis), or mycophenolate mofetil (immunosuppressant).
Prevalence:
How common the health condition is within a specific population.
Occurs in 10-30% of patients receiving immune checkpoint inhibitors.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Combination immunotherapy, pre-existing autoimmune conditions, and genetic predisposition.
Prognosis:
The expected outcome or course of the condition over time.
Generally good with early intervention, though some effects, such as endocrine dysfunction, may require lifelong hormone replacement.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Chronic organ dysfunction, severe inflammatory syndromes, or treatment discontinuation due to toxicity.